MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zwart, R.
Right arrow Articles by Vijverberg, H. P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zwart, R.
Right arrow Articles by Vijverberg, H. P. M.

Molecular Pharmacology, Volume 52, Issue 5, 886-895

Potentiation and Inhibition of Neuronal Nicotinic Receptors by Atropine: Competitive and Noncompetitive Effects

Ruud Zwart and Henk P. M. Vijverberg

Research Institute of Toxicology, Utrecht University, NL-3508 TD Utrecht, The Netherlands

Atropine, the classic muscarinic receptor antagonist, inhibits ion currents mediated by neuronal nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes. At the holding potential of -80 mV, 1 µM atropine inhibits 1 mM acetylcholine-induced inward currents mediated by rat alpha 2beta 2, alpha 2beta 4, alpha 3beta 2, alpha 3beta 4, alpha 4beta 2, alpha 4beta 4, and alpha 7 nicotinic receptors by 12-56%. Inward currents induced with a low agonist concentration are equally inhibited (alpha 3beta 2, alpha 3beta 4), less inhibited (alpha 2beta 4, alpha 7), or potentiated (alpha 4beta 2, alpha 4beta 4) by 1 µM atropine. Effects on the more sensitive alpha 4beta 4 nicotinic receptors were investigated in detail by systematic variation of acetylcholine and atropine concentrations and of membrane potential. At high agonist concentration, atropine inhibits alpha 4beta 4 nicotinic receptor-mediated ion current in a noncompetitive, voltage-dependent way with IC50 values of 655 nM at -80 mV and of 4.5 µM at -40 mV. At low agonist concentration, 1 µM atropine potentiates alpha 4beta 4 nicotinic receptor-mediated ion current. This potentiating effect is surmounted by high concentrations of acetylcholine, indicating a competitive interaction of atropine with the nicotinic receptor, and potentiation is also reversed at high atropine concentrations. Steady state effects of acetylcholine and atropine are accounted for by a model for combined receptor occupation and channel block, in which atropine acts on two distinct sites. The first site is associated with noncompetitive ion channel block. The second site is associated with competitive potentiation, which appears to occur when the agonist recognition sites of the receptor are occupied by acetylcholine and atropine. The apparent affinity of atropine for the agonist recognition sites of the alpha 4beta 4 nicotinic acetylcholine receptor is estimated to be 29.9 µM.


Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
L. Jiang and L. W. Role
Facilitation of Cortico-Amygdala Synapses by Nicotine: Activity-Dependent Modulation of Glutamatergic Transmission
J Neurophysiol, April 1, 2008; 99(4): 1988 - 1999.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Lopes, E. F. R. Pereira, H.-Q. Wu, P. Purushottamachar, V. Njar, R. Schwarcz, and E. X. Albuquerque
Competitive Antagonism between the Nicotinic Allosteric Potentiating Ligand Galantamine and Kynurenic Acid at {alpha}7* Nicotinic Receptors
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 48 - 58.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Bodenstein, D. P. Venter, and C. B. Brink
Phenoxybenzamine and Benextramine, but Not 4-Diphenylacetoxy-N-[2-chloroethyl]piperidine Hydrochloride, Display Irreversible Noncompetitive Antagonism at G Protein-Coupled Receptors
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 891 - 905.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
K. K. Rau, R. D. Johnson, and B. Y. Cooper
Nicotinic AChR in Subclassified Capsaicin-Sensitive and -Insensitive Nociceptors of the Rat DRG
J Neurophysiol, March 1, 2005; 93(3): 1358 - 1371.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. J. G. M. Smulders, T. J. H. Bueters, S. Vailati, R. G. D. M. van Kleef, and H. P. M. Vijverberg
Block of Neuronal Nicotinic Acetylcholine Receptors by Organophosphate Insecticides
Toxicol. Sci., December 1, 2004; 82(2): 545 - 554.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. J. G. M. Smulders, R. G. D. M. Van Kleef, A. de Groot, C. Gotti, and H. P. M. Vijverberg
A Noncompetitive, Sequential Mechanism for Inhibition of Rat {alpha}4{beta}2 Neuronal Nicotinic Acetylcholine Receptors by Carbamate Pesticides
Toxicol. Sci., November 1, 2004; 82(1): 219 - 227.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. A. Gonzalez, R. Farre, and P. Clave
Different responsiveness of excitatory and inhibitory enteric motor neurons in the human esophagus to electrical field stimulation and to nicotine
Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G299 - G306.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Samochocki, A. Hoffle, A. Fehrenbacher, R. Jostock, J. Ludwig, C. Christner, M. Radina, M. Zerlin, C. Ullmer, E. F. R. Pereira, et al.
Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors
J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1024 - 1036.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. V. Rothlin, M. I. Lioudyno, A. F. Silbering, P. V. Plazas, M. E. G. Casati, E. Katz, P. S. Guth, and A. B. Elgoyhen
Direct Interaction of Serotonin Type 3 Receptor Ligands with Recombinant and Native alpha 9alpha 10-Containing Nicotinic Cholinergic Receptors
Mol. Pharmacol., May 1, 2003; 63(5): 1067 - 1074.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
W. A. Luft, Y. Ming, and W. K. Stell
Variable Effects of Previously Untested Muscarinic Receptor Antagonists on Experimental Myopia
Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1330 - 1338.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Zuo, J. Z. Yeh, and T. Narahashi
Dual Action of n-Butanol on Neuronal Nicotinic alpha 4beta 2 Acetylcholine Receptors
J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1143 - 1152.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J.-J. Koksma, R. E. van Kesteren, T. W. Rosahl, R. Zwart, A. B. Smit, H. Luddens, and A. B. Brussaard
Oxytocin Regulates Neurosteroid Modulation of GABAA Receptors in Supraoptic Nucleus around Parturition
J. Neurosci., February 1, 2003; 23(3): 788 - 797.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Song, H. S. Sekhon, Y. Jia, J. A. Keller, J. K. Blusztajn, G. P. Mark, and E. R. Spindel
Acetylcholine Is Synthesized by and Acts as an Autocrine Growth Factor for Small Cell Lung Carcinoma
Cancer Res., January 1, 2003; 63(1): 214 - 221.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
E. Christophe, A. Roebuck, J. F. Staiger, D. J. Lavery, S. Charpak, and E. Audinat
Two Types of Nicotinic Receptors Mediate an Excitation of Neocortical Layer I Interneurons
J Neurophysiol, September 1, 2002; 88(3): 1318 - 1327.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. I Eger II, Y. Zhang, M. Laster, P. Flood, J. J. Kendig, and J. M. Sonner
Acetylcholine Receptors Do Not Mediate the Immobilization Produced by Inhaled Anesthetics
Anesth. Analg., June 1, 2002; 94(6): 1500 - 1504.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Hsiao, D. Dweck, and C. W. Luetje
Subunit-Dependent Modulation of Neuronal Nicotinic Receptors by Zinc
J. Neurosci., March 15, 2001; 21(6): 1848 - 1856.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Zwart and H. P. M. Vijverberg
Four Pharmacologically Distinct Subtypes of alpha 4beta 2 Nicotinic Acetylcholine Receptor Expressed in Xenopus laevis Oocytes
Mol. Pharmacol., December 1, 1998; 54(6): 1124 - 1131.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics